291 |
CLAMOVID FOR INJECTION 1.2 G |
AMOXICILLIN SODIUM EQ.TO AMOXICILLIN 1000 MG, CLAVULANIC ACID 200 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
UPPER AND LOWER RESPIRATORY TRACT INFECTION, GENITO-URINARY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTION |
NULL |
BMS PHARMA SOLE CO.,LTD |
REYOUNG PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
04 I 5729/24 |
2024-04-26 |
2027-04-25 |
View |
292 |
CLAMOVID GRANULES 228 MG/5ML |
EACH 5 ML CONTAINS: AMOXICILLIN TRIHYDRATE 223.96 MG EQ.TO AMOXICILLIN 200 MG, CLAVULANIC ACID 28.5 MG |
DRY POWDER FOR ORAL SUSPENSION |
BOTTLE |
FOR THE TREATMENT OF THE FOLLOWING INFECTIONS IN ADULTS AND CHILDREN: ACUTE BACTERIAL SINUSITIS, ACUTE OTITIS MEDIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, CYSTITIS, PYELONEPHRITIS, SKIN AND SOF TISSUE INFECTION, BONE AND JOINT INFECTION |
NULL |
BMS PHARMA SOLE CO.,LTD |
BILIM ILAC SANAYI VE TICARET ANONIM SIRKETI |
TURKIE |
CERTIFICATE RELEASED |
04 I 5730/24 |
2024-04-26 |
2027-04-25 |
View |
293 |
CLOFENAC 50 |
DICLOFENAC SODIUM 50 MG |
ENTERIC COATED TABLET |
BLISTERPACK |
USED FOR RELIEF OF PAIN AND INFLAMMATION IN CONDITIONS SUCH AS RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ANKYLLOSING SPONDYLITIS, ACUTE GOUT AND FOLLOWING SOME SURGICAL PROCEDURES |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 4701/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
294 |
CLOFENAC SR |
DICLOFENAC SODIUM 100 MG |
TABLET |
BLISTERPACK |
USED FOR RELIEF OF PAIN AND INFLAMMATION IN CONDITIONS SUCH AS RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ANKYLOSING SPONDYLITIS, ACUTE GOUT AND FOLLOWING SOME SURGICAL PROCEDURES |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 4702/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
295 |
CLOXACAP 500 |
CLOXACILLIN SODIUM 500 MG |
CAPSULE |
BLISTERPACK |
INFECTION CAUSED BY PENICILLINASE-PRODUCING STAPHYLOCOCCI, RESPIRATORY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, DISSEMINATED INFECTION CAUSED BY PNEUMOCOCCI, GROUP A BETA-HEMOLYTIC STREPTOCOCCI AND PENICILLIN G-RESISTANT AND PENICILLIN G-SENSITIVE STAPHYLOCCI |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4909/20 |
07-JUN-2023 |
06-JUN-2026 |
View |
296 |
COLODIUM |
LOPERAMIDE HYDROCHLORIDE 2 MG |
CAPSULE |
ALU-PVC BLISTER |
FOR THE RELIEF OF ACUTE NONSPECIFIC DIARRHEA AND OF CHRONIC DIARRHEA ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE, AS WELL AS TO REDUCE THE VOLUME OF DISCHARGE FORM ILEOSTOMIES |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 5447/23 |
11-APR-2023 |
10-APR-2026 |
View |
297 |
CORTISONE |
HYDROCORTISONE ( BASE) 1% W/W |
CREAM |
TUBE |
FOR RELIEF OR TREATMENT OF :
- MINOR SKIN IRRITATION, ITCHING, AND RASHES DUE TO ECZEMA, INSECT BITES, POISON IVY,OAK, OR SUMAC DERMATITIS, DETERGENTS, COSMETICS AND JEWELLERY.
- ANOGENITAL PRURITUS |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
07 I 4166/16 |
07-JUN-2023 |
06-JUN-2026 |
View |
298 |
COSAMINE PLUS |
GLUCOSAMINE POTASSIUM SULFATE 331.60 MG EQ.TO GLUCOSAMINE SULFATE 250 MG, CHONDROITIN SODIUM SULFATE 240 MG EQ.TO CHONDROITIN SULFATE 200 MG |
CAPSULE |
BOTTLE |
ADJUNCTIVE THERAPY IN OSTEOARTHRITIS |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4918/20 |
07-JUN-2023 |
06-JUN-2026 |
View |
299 |
DIABETMIN |
METFORMIN HYDROCHLORIDE 500 MG |
FILM COATED TABLET |
BLISTERPACK |
TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 2) IN ADULTS, NOT RESPONDING TO EXCERCISE AND DIETARY MODIFICATION, DIABETMIN MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENT, OR WITH INSULIN. |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4910/20 |
07-JUN-2023 |
06-JUN-2026 |
View |
300 |
DIABETMIN 850 |
METFORMIN HYDROCHLORIDE 850 MG |
FILM COATED TABLET |
BLISTERPACK |
TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 2) IN ADULTS, NOT RESPONDING TO EXCERCISE AND DIETARY MODIFICATION, DIABETMIN MAY BE USED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ORAL ANTIDIABETIC AGENT, OR WITH INSULIN. |
NULL |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4911/20 |
07-JUN-2023 |
06-JUN-2026 |
View |